BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND DDX5, HLR1, 1655, ENSG00000108654, P17844, DKFZp686J01190, p68, G17P1, HUMP68
9 results:

  • 1. The feedback loop of AURKA/ddx5/TMEM147-AS1/let-7 drives lipophagy to induce cisplatin resistance in epithelial ovarian cancer.
    Shao Y; Li H; Wu Y; Wang X; Meng J; Hu Z; Xia L; Cao S; Tian W; Zhang Y; Feng X; Zhang X; Li Y; Yang G
    Cancer Lett; 2023 Jul; 565():216241. PubMed ID: 37217070
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. ovarian teratoma-associated anti-N-methyl-D-aspartate receptor encephalitis: a clinical analysis of 5 cases.
    He LD; Zhang X; Wu J
    Ginekol Pol; 2023; 94(6):451-455. PubMed ID: 36597802
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first-in-class proof-of-concept phase 2 study.
    Lee JM; Nair J; Zimmer A; Lipkowitz S; Annunziata CM; Merino MJ; Swisher EM; Harrell MI; Trepel JB; Lee MJ; Bagheri MH; Botesteanu DA; Steinberg SM; Minasian L; Ekwede I; Kohn EC
    Lancet Oncol; 2018 Feb; 19(2):207-215. PubMed ID: 29361470
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Confluence analysis of multiple omics on platinum resistance of ovarian cancer.
    Ye X
    Eur J Gynaecol Oncol; 2015; 36(5):514-9. PubMed ID: 26513874
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The clinical characteristics and outcomes of cases with pure ovarian clear cell, mixed type and high-grade serous adenocarcinoma.
    Kucukgoz Gulec U; Paydas S; Guzel AB; Vardar MA; Khatib G; Gumurdulu D
    Arch Gynecol Obstet; 2015 Oct; 292(4):923-9. PubMed ID: 25855053
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study.
    Jensen A; Sharif H; Frederiksen K; Kjaer SK
    BMJ; 2009 Feb; 338():b249. PubMed ID: 19196744
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Effect of trastuzumab on tumor cell lines shedding high or low level of HER-2 ECD].
    Liu CY; Yang W; Li JF; Sun SL; Shou CC
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):101-5. PubMed ID: 17645842
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Serologic analysis of ovarian tumor antigens reveals a bias toward antigens encoded on 17q.
    Stone B; Schummer M; Paley PJ; Thompson L; Stewart J; Ford M; Crawford M; Urban N; O'Briant K; Nelson BH
    Int J Cancer; 2003 Mar; 104(1):73-84. PubMed ID: 12532422
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Evaluation of endometrial changes in women with cyclical mastalgia].
    Wypych K; Spiewankiewicz B; Sawicki W
    Ginekol Pol; 1995 Aug; 66(8):451-6. PubMed ID: 8675069
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.